{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:45:34Z","timestamp":1792273534420,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10735-026-10940-x","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:58:46Z","timestamp":1786593526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GATA1 knockdown enhances CD8+ T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation"],"prefix":"10.1007","volume":"57","author":[{"given":"Juan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"10940_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.6026\/97320630019556","volume":"19","author":"I Alshami","year":"2023","unstructured":"Alshami I, Alattas RO, Waad AA, Anwar AS (2023) Role of T cells in cervical cancer. Bioinformation 19:556\u2013561","journal-title":"Bioinformation"},{"key":"10940_CR2","first-page":"697","volume":"55","author":"F Bie","year":"2019","unstructured":"Bie F, Wang G, Qu X, Wang Y, Huang C, Wang Y et al (2019) Loss of FGL1 induces epithelial-mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma. Int J Oncol 55:697\u2013707","journal-title":"Int J Oncol"},{"key":"10940_CR3","first-page":"505","volume":"71","author":"PE Castle","year":"2021","unstructured":"Castle PE, Einstein MH, Sahasrabuddhe VV (2021) Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin 71:505\u2013526","journal-title":"CA Cancer J Clin"},{"key":"10940_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41423-020-00570-y","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Wu X, Yao H, Yan Z, Guo T et al (2021) CD147 regulates antitumor CD8(+) T-cell responses to facilitate tumor-immune escape. Cell Mol Immunol 18:1995\u20132009","journal-title":"Cell Mol Immunol"},{"key":"10940_CR5","first-page":"1685","volume":"15","author":"F Chen","year":"2023","unstructured":"Chen F, Shen L, Wang Y, Chen Y, Pan X, Liang H et al (2023) Signatures of immune cell infiltration for predicting immune escape and immunotherapy in cervical cancer. Aging 15:1685\u20131698","journal-title":"Aging"},{"key":"10940_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12010-023-04459-0","volume":"196","author":"P Chen","year":"2024","unstructured":"Chen P, Liu X, Liu Y, Bao X, Wu Q (2024) ARHGAP18 is upregulated by transcription factor GATA1 promotes the proliferation and invasion in hepatocellular carcinoma. Appl Biochem Biotechnol 196:679\u2013689","journal-title":"Appl Biochem Biotechnol"},{"key":"10940_CR7","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1101\/gr.098921.109","volume":"19","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Wu W, Kumar SA, Yu D, Deng W, Tripic T et al (2009) Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 19:2172\u20132184","journal-title":"Genome Res"},{"key":"10940_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11864-020-00790-4","volume":"21","author":"L Chitsike","year":"2020","unstructured":"Chitsike L, Duerksen-Hughes P (2020) The potential of immune checkpoint blockade in cervical cancer: can combinatorial regimens maximize response? A review of the literature. Curr Treat Options Oncol 21:95","journal-title":"Curr Treat Options Oncol"},{"key":"10940_CR9","doi-asserted-by":"publisher","first-page":"5478574","DOI":"10.1155\/2020\/5478574","volume":"2020","author":"H Ding","year":"2020","unstructured":"Ding H, Xiong XX, Fan GL, Yi YX, Chen YR, Wang JT et al (2020) The new biomarker for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) based on public database mining. Biomed Res Int 2020:5478574","journal-title":"Biomed Res Int"},{"key":"10940_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.mcna.2020.08.006","volume":"104","author":"TJ Eun","year":"2020","unstructured":"Eun TJ, Perkins RB (2020) Screening for cervical cancer. Med Clin North Am 104:1063\u20131078","journal-title":"Med Clin North Am"},{"key":"10940_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.mcna.2022.10.006","volume":"107","author":"K Gavinski","year":"2023","unstructured":"Gavinski K, DiNardo D (2023) Cervical cancer screening. Med Clin North Am 107:259\u2013269","journal-title":"Med Clin North Am"},{"key":"10940_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12951-021-00805-8","volume":"19","author":"C Gong","year":"2021","unstructured":"Gong C, Yu X, Zhang W, Han L, Wang R, Wang Y et al (2021) Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles. J Nanobiotechnol 19:58","journal-title":"J Nanobiotechnol"},{"key":"10940_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.soncn.2019.02.003","volume":"35","author":"CA Johnson","year":"2019","unstructured":"Johnson CA, James D, Marzan A, Armaos M (2019) Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs 35:166\u2013174","journal-title":"Semin Oncol Nurs"},{"key":"10940_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aar3451","author":"CJ Kearney","year":"2018","unstructured":"Kearney CJ, Vervoort SJ, Hogg SJ, Ramsbottom KM, Freeman AJ, Lalaoui N et al (2018) Tumor immune evasion arises through loss of TNF sensitivity. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aar3451","journal-title":"Sci Immunol"},{"key":"10940_CR15","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/153537020322801107","volume":"228","author":"HA LaVoie","year":"2003","unstructured":"LaVoie HA (2003) The role of GATA in mammalian reproduction. Exp Biol Med 228:1282\u20131290","journal-title":"Exp Biol Med"},{"key":"10940_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.semradonc.2021.02.008","volume":"31","author":"MY Lee","year":"2021","unstructured":"Lee MY, Allen CT (2021) Immunotherapy for HPV malignancies. Semin Radiat Oncol 31:361\u2013370","journal-title":"Semin Radiat Oncol"},{"key":"10940_CR17","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509\u2013W514","journal-title":"Nucleic Acids Res"},{"key":"10940_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00709-019-01477-w","volume":"257","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhu Y, Li F, Xie Y (2020) GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway. Protoplasma 257:901\u2013910","journal-title":"Protoplasma"},{"key":"10940_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L et al (2021) N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer 20:105","journal-title":"Mol Cancer"},{"key":"10940_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081854","author":"F Martinez-Rodriguez","year":"2021","unstructured":"Martinez-Rodriguez F, Limones-Gonzalez JE, Mendoza-Almanza B, Esparza-Ibarra EL, Gallegos-Flores PI, Ayala-Lujan JL et al (2021) Understanding cervical cancer through proteomics. Cells. https:\/\/doi.org\/10.3390\/cells10081854","journal-title":"Cells"},{"key":"10940_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11912-021-01052-8","volume":"23","author":"D Mauricio","year":"2021","unstructured":"Mauricio D, Zeybek B, Tymon-Rosario J, Harold J, Santin AD (2021) Immunotherapy in cervical cancer. Curr Oncol Rep 23:61","journal-title":"Curr Oncol Rep"},{"key":"10940_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3324\/haematol.2019.246355","volume":"105","author":"AR Migliaccio","year":"2020","unstructured":"Migliaccio AR (2020) GATA1 gets personal. Haematologica 105:852\u2013854","journal-title":"Haematologica"},{"key":"10940_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M (2023) Cervical cancer screening: a review. JAMA 330:547\u2013558","journal-title":"JAMA"},{"key":"10940_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-021-01161-8","volume":"14","author":"W Qian","year":"2021","unstructured":"Qian W, Zhao M, Wang R, Li H (2021) Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target. J Hematol Oncol 14:147","journal-title":"J Hematol Oncol"},{"key":"10940_CR25","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V et al (2024) JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res 52:D174\u2013D182","journal-title":"Nucleic Acids Res"},{"key":"10940_CR26","doi-asserted-by":"publisher","first-page":"20829","DOI":"10.1002\/jcp.28688","volume":"234","author":"P Riccio","year":"2019","unstructured":"Riccio P, Sessa R, de Nicola S, Petruzziello F, Trombetti S, Menna G et al (2019) GATA-1 isoforms differently contribute to the production and compartmentation of reactive oxygen species in the myeloid leukemia cell line K562. J Cell Physiol 234:20829\u201320846","journal-title":"J Cell Physiol"},{"key":"10940_CR27","doi-asserted-by":"publisher","first-page":"785091","DOI":"10.3389\/fimmu.2021.785091","volume":"12","author":"AP Shi","year":"2021","unstructured":"Shi AP, Tang XY, Xiong YL, Zheng KF, Liu YJ, Shi XG et al (2021) Immune checkpoint LAG3 and its ligand FGL1 in cancer. Front Immunol 12:785091","journal-title":"Front Immunol"},{"key":"10940_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105330","author":"Y Son","year":"2021","unstructured":"Son Y, Shin NR, Kim SH, Park SC, Lee HJ (2021) Fibrinogen-like protein 1 modulates sorafenib resistance in human hepatocellular carcinoma cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22105330","journal-title":"Int J Mol Sci"},{"key":"10940_CR29","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1080\/15384101.2019.1666611","volume":"18","author":"Y Sun","year":"2019","unstructured":"Sun Y, Xiong X, Wang X (2019) HIF1alpha\/miR-199a\/ADM feedback loop modulates the proliferation of human dermal microvascular endothelial cells (HDMECs) under hypoxic condition. Cell Cycle 18:2998\u20133009","journal-title":"Cell Cycle"},{"key":"10940_CR30","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556\u2013W560","journal-title":"Nucleic Acids Res"},{"key":"10940_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.21037\/tlcr-22-151","volume":"11","author":"XY Tang","year":"2022","unstructured":"Tang XY, Xiong YL, Shi AP, Sun Y, Han Q, Lv Y et al (2022) The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating MYC-target genes. Transl Lung Cancer Res 11:404\u2013419","journal-title":"Transl Lung Cancer Res"},{"key":"10940_CR32","doi-asserted-by":"publisher","first-page":"113362","DOI":"10.1016\/j.celrep.2023.113362","volume":"42","author":"T Tian","year":"2023","unstructured":"Tian T, Xie X, Yi W, Zhou Y, Xu Y, Wang Z et al (2023) FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation. Cell Rep 42:113362","journal-title":"Cell Rep"},{"key":"10940_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA (2015) Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 15:388\u2013400","journal-title":"Nat Rev Immunol"},{"key":"10940_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","volume":"176","author":"J Wang","year":"2019","unstructured":"Wang J, Sanmamed MF, Datar I, Su TT, Ji L, Sun J et al (2019) Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3. Cell 176:334\u2013347","journal-title":"Cell"},{"key":"10940_CR35","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1002\/cam4.3151","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, Wei W, Tang Q, Lu L, Luo Z, Li W et al (2020) Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti-Lag-3 via reducing FGL1 expression. Cancer Med 9:7125\u20137136","journal-title":"Cancer Med"},{"key":"10940_CR36","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/cam4.3833","volume":"10","author":"Y Wang","year":"2021","unstructured":"Wang Y, He M, Zhang G, Cao K, Yang M, Zhang H et al (2021) The immune landscape during the tumorigenesis of cervical cancer. Cancer Med 10:2380\u20132395","journal-title":"Cancer Med"},{"key":"10940_CR37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/ol.2022.13455","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xia W, Shen F, Zhou J, Gu Y, Chen Y (2022) TRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1. Oncol Lett 24:334","journal-title":"Oncol Lett"},{"key":"10940_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13046-023-02758-2","volume":"42","author":"D Wang","year":"2023","unstructured":"Wang D, Wu S, He J, Sun L, Zhu H, Zhang Y et al (2023) FAT4 overexpression promotes antitumor immunity by regulating the beta-catenin\/STT3\/PD-L1 axis in cervical cancer. J Exp Clin Cancer Res 42:222","journal-title":"J Exp Clin Cancer Res"},{"key":"10940_CR39","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/pro.2760","volume":"24","author":"L Wilkinson-White","year":"2015","unstructured":"Wilkinson-White L, Lester KL, Ripin N, Jacques DA, Mitchell Guss J, Matthews JM (2015) GATA1 directly mediates interactions with closely spaced pseudopalindromic but not distantly spaced double GATA sites on DNA. Protein Sci 24:1649\u20131659","journal-title":"Protein Sci"},{"key":"10940_CR40","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1038\/s41598-017-02242-w","volume":"7","author":"YY Xu","year":"2017","unstructured":"Xu YY, Jin R, Zhou GP, Xu HG (2017) Involvement of GATA1 and Sp3 in the activation of the murine STING gene promoter in NIH3T3 cells. Sci Rep 7:2090","journal-title":"Sci Rep"},{"key":"10940_CR41","doi-asserted-by":"publisher","first-page":"810269","DOI":"10.3389\/fonc.2022.810269","volume":"12","author":"Q Yan","year":"2022","unstructured":"Yan Q, Lin HM, Zhu K, Cao Y, Xu XL, Zhou ZY et al (2022) Immune checkpoint FGL1 expression of circulating tumor cells is associated with poor survival in curatively resected hepatocellular carcinoma. Front Oncol 12:810269","journal-title":"Front Oncol"},{"key":"10940_CR42","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2147\/CMAR.S274204","volume":"13","author":"J Yang","year":"2021","unstructured":"Yang J, Niu H, Chen X (2021a) GATA1-activated HNF1A-AS1 facilitates the progression of triple-negative breast cancer via sponging miR-32-5p to upregulate RNF38. Cancer Manag Res 13:1357\u20131369","journal-title":"Cancer Manag Res"},{"key":"10940_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12951-021-01073-2","volume":"19","author":"L Yang","year":"2021","unstructured":"Yang L, Li F, Cao Y, Liu Q, Jing G, Niu J et al (2021b) Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy. J Nanobiotechnol 19:328","journal-title":"J Nanobiotechnol"},{"key":"10940_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-019-03523-w","volume":"457","author":"J Yu","year":"2019","unstructured":"Yu J, Liu M, Liu H, Zhou L (2019) GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway. Mol Cell Biochem 457:191\u2013199","journal-title":"Mol Cell Biochem"},{"key":"10940_CR45","doi-asserted-by":"publisher","first-page":"1105265","DOI":"10.3389\/fimmu.2023.1105265","volume":"14","author":"L Yu","year":"2023","unstructured":"Yu L, Lanqing G, Huang Z, Xin X, Minglin L, Fa-Hui L et al (2023) T cell immunotherapy for cervical cancer: challenges and opportunities. Front Immunol 14:1105265","journal-title":"Front Immunol"},{"key":"10940_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.31083\/j.fbl2709261","volume":"27","author":"D Zeng","year":"2022","unstructured":"Zeng D, Zheng J, Feng S, Fan P, Zhao D (2022) Human Parvovirus B19 nonstructural protein 1 regulates GATA1 expression via the Notch signaling pathway in K562 cell line. Front Biosci 27:261","journal-title":"Front Biosci"},{"key":"10940_CR47","first-page":"1465","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Qiao HX, Zhou YT, Hong L, Chen JH (2018) Fibrinogen-like-protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis. Mol Med Rep 18:1465\u20131472","journal-title":"Mol Med Rep"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10940-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10940-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10940-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:26Z","timestamp":1792271966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10940-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10940"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10940-x","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were reviewed and approved by the Animal Ethics Committee of Tangdu Hospital, Air Force Military Medical University. The animal experiments have been carried out in accordance with the ARRIVE guidelines.(Approval number: GKJ-Y-202503-063).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"269"}}